Lv3
280 积分 2022-11-18 加入
免疫检查点抑制剂相关性胆管炎诊治研究进展
1个月前
已完结
Clinical features, treatment, and outcome of nivolumab-induced cholangitis
1个月前
已完结
第4回 irAE胆管炎の診断と治療
1个月前
已关闭
Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics
1个月前
已完结
New Toxicity Signals Associated With Ixekizumab
1个月前
已完结
Exploring drug-induced pemphigus findings from the FDA adverse event reporting system database
1个月前
已完结
Unmasking a rare complication: Immune checkpoint inhibitors (ICIs) and Vogt-Koyanagi-Harada (VKH) syndrome
1个月前
已关闭
Anaphylaxis in Risky Populations
1个月前
已完结
Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS
9个月前
已完结
Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS
10个月前
已完结
皖公网安备34019202002308
